White cell reduction during plateletpheresis: A comparison of three blood cell separators

Transfusion

Volumn 39, Issue 6, 1999, Pages 572-577

  Moog, Rainer ^a   Muller N ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOIMMUNIZATION; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION REACTION; BLOOD VOLUME; CELL SEPARATION; CYTOKINE PRODUCTION; DEVICE; FLUIDIZED BED; HEMATOCRIT; HUMAN; INFECTION; LEUKOCYTE; LEUKOCYTE COUNT; NORMAL HUMAN; THROMBOCYTE COUNT; THROMBOCYTOPHERESIS;

BLOOD CELLS; CELL SEPARATION; HEMATOCRIT; HUMANS; LEUKOCYTE COUNT; PLATELET COUNT; PLATELETPHERESIS;

EID: 0033028824     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39060572.x     Document Type: Article

References (45)

1. Fisher M, Chapman JR, Ting A, Morris PJ. Alloimmunization to HLA antigens following transfusion with leucocyte-poor and purified platelet suspensions. Vox Sang 1985;49:331-5.
2. Andreu G, Dewailly J, Leberre C, et al. Prevention of HLA immunization with leukocyte-poor packed red cells and platelet concentrates obtained by filtration. Blood 1988;72:964-9.
3. Sniecinski I, O'Donnell MR, Nowicki B, Hill LR. Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 1988;71:1402-7.
4. Meryman HT. Transfusion-induced alloimmunization and immunosuppression and the effects of leukocyte depletion. Transfus Med Rev 1989;3:180-93.
5. Bowden RA, Slichter SJ, Sayers MH, et al. Use of leukocyte-depleted platelets and cytomegalovirus-seronegative red blood cells for prevention of primary cytomegalovirus infection after marrow transplant. Blood 1991;78:246-50.
6. De Graan-Hentzen YCE, Gratama JW, Mudde GC, et al. Prevention of cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products. Transfusion 1989;29:757-60.
7. Lang DJ, Ebert PA, Rodgers BM, et al. Reduction of postperfusion cytomegalovirus-infections following the use of leukocyte depleted blood. Transfusion 1977;17:391-5.
8. Gilbert GL, Hayes K, Hudson IL, James J. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Lancet 1989;1:1228-31.
9. Heddle NM, Klama LN, Griffith L, et al. A prospective study to identify the risk factors associated with acute transfusion reactions to platelet and red cell transfusions. Transfusion 1993;33:794-7.
10. Heddle NM, Klama L, Singer J, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med 1994;331:625-8.
11. Snyder EL. Transfusion reaction: state of the art. Vox Sang 1994;67(Suppl 3):143-6.
12. Muylle L, Peetermans ME. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates. Vox Sang 1994;66:14-7.
13. Aye MT, Palmer DS, Giulivi A, Hashemi S. Effect of filtration of platelet concentrate on the accumulation of cytokines and platelet release factors during storage. Transfusion 1995;35:117-24.
14. Gottschall JL, Johnston VL, Rzad L, et al. Importance of white blood cells in platelet storage. Vox Sang 1984;47:101-7.
15. Pietersz RN, de Korte D, Reesink HW, et al. Preparation of leukocyte-poor platelet concentrates from buffy coats. III. Effects of leukocyte contamination on storage conditions. Vox Sang 1988;55:14-20.
16. Sloand EM, Klein HG. Effects of white cells on platelets during storage. Transfusion 1990;30:333-8.
17. Eernisse JG, Brand A. Prevention of platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Exp Hematol 1981;9:77-83.
18. Bowden RA, Slichter SJ, Sayers M, et al. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. Blood 1995;86:3598-603.
19. Murphy MF, Metcalfe P, Thomas H, et al. Use of leucocyte-poor blood components and HLA-matched-platelet donors to prevent HLA alloimmunization. Br J Haematol 1986;62:529-34.
20. Saarinen UM, Kekomaki R, Siimes MA, Myllyla G. Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components. Blood 1990;75:512-7.
21. Bock M, Himmelsbach S, Gudden A et al. [Preparation of leukocyte-depleted thrombocyte concentrate: in-vitro testing of a new filtration system (PL 100)] (Engl abstract). Infusionstherapie 1991;18:30-2.
22. Muller N. Filtration of platelet concentrates. Infusionstherapie 1991;18(Suppl 1):19-23.
23. Kao KJ, Mickel M, Braine HG, et al. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. Transfusion 1995;35:13-9.
24. Fournel JJ, Zingsem J, Riggert J, et al. A multicenter evaluation of the routine use of a new white cell-reduction apheresis system for collection of platelets. Transfusion 1997;37:487-92.
25. Zingsem J, Zimmermann R, Weisbach V, et al. Comparison of COBE white cell-reduction system and standard plateletpheresis protocols in the same donors. Transfusion 1997;37:1045-9.
26. Riggert J, Humpe A, Simson G, Kohler M. Quality and safety of platelet apheresis concentrates produced with a new leukocyte reduction system. Vox Sang 1998;74:182-8.
27. Moog R. [Importance of the interface position in thrombocytapheresis with the AS 104 cell separator] (Engl abstract). Infusionsther Transfusionsmed 1992;19:61-3.
28. Burgstaler EA, Pineda AA, Potter BM, Brown R. Plateletapheresis with a next generation blood cell separator. J Clin Apheresis 1997;12:55-62.
29. Moog R, Valbonesi M, Carlier P, et al. Collection of platelets and peripheral progenitor cells with the Fresenius AS.TEC 204 blood cell separator. J Clin Apheresis 1997;12:126-9.
30. Valbonesi M, Lercari G, Florio G, et al. Erythrothrombocytapheresis and plasmathrombocytapheresis with storage in T-sol of platelets collected by the new Amicus cell separator. Int J Artif Organs 1997;20:272-6.
31. [Guidelines for blood group determination and blood transfusion (hemotherapy)]. Rev ed. Cologne: Deutscher Ärzteverlag, 1996.
32. Broberg H, Giannitsis D, Kaeser R, et al. [Performance of preparative hemapheresis for the collection of blood components. Recommendations of the Permanent Hemapheresis Commission of the German Society for Transfusion Medicine and Immunhematology]. Infusionsther Transfusionsmed 1994;21:222-31.
33. Masse M, Naegelen C, Pellegrini N, et al. Validation of a simple method to count very low white cell concentrations in filtered red cells and platelets. Transfusion 1992;32:565-71.
34. Scheffe H. A method of judging all contrasts in analysis of variance. Biometrika 1953;40:87-104.
35. Moog R, Müller N, Goergens D. Platelet collection with the Amicus and the AS.TEC 204 blood cell separators. Transfusion 1998;38:285-9.
36. Council of Europe. Guide to the preparation, use, and quality assurance of blood components. 3rd ed. Strasbourg: Council of Europe Press, 1997.
37. Kretschmer V. [Comparison of different plateletpheresis systems] (Engl abstract). Infusionstherapie 1991;18:188-90,193-5.
38. Valbonesi M, Frisoni R, Fella M, et al. Plateletpheresis with the new Fresenius AS 104 blood cell separator. J Clin Apheresis 1991;6:84-7.
39. Kretschmer V, Biehl M, Coffe C, et al. New features of the Fresenius blood cell separator AS 104. In: Agishi T, Kawamura A, Mineshima M, eds. Therapeutic plasmapheresis. Ziest, the Netherlands: International Science Publishers, 1993:851-5.
40. Muller N, Kretschmer V, Godehardt E, et al. Improvement of separation efficiency and concentrate purity of the Fresenius AS 104: results of a multicenter study. Transfus Sci 1993;14:105-14.
41. Moog R, Muller N. Results with new software for plateletpheresis systems. Transfus Sci 1994;15:313-7.
42. Moog R, Muller N. Comparison of different protocols in plateletpheresis with the Haemonetics MCS 3p blood cell separator with respect to parameters of product quality. Infusionsther Transfusionsmed 1995;22:244-8.
43. Szymanski I, Civarella D, Rososhansky S, et al. Evaluation of platelets collected by a new apheresis device. J Clin Apheresis 1993;8:66-71.
44. ™ blood cell separator. Transfus Med 1995; 5:293-6.
45. Moog R, Muller N, Kobke AC, Kalb R. Leukocyte filtration of single-donor platelet units through an integrated filter system for the Fresenius AS 104 blood cell separator. Vox Sang 1997;72:107-10.